Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[S,S]-Reboxetine Dose-Range Finding Trial: A 16-Week, Randomized, Double-Blind, Placebo And An Active Comparator Controlled, Multi-Center Trial Of [S,S]-Reboxetine In Patients With Postherpetic Neuralgia (PHN)

NCT00288652 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00288652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00288652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[S,S]-Reboxetine Dose-Range Finding Trial: A 16-Week, Randomized, Double-Blind, Placebo And An Active Comparator Controlled, Multi-Center Trial Of [S,S]-Reboxetine In Patients With Postherpetic Neuralgia (PHN)
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2006
Completion date
February 28, 2007
Enrollment
280
Sites
79

Conditions

As the registry lists them; a condition with its own page is linked.

pain